{"id":180744,"date":"2025-11-14T18:20:08","date_gmt":"2025-11-14T18:20:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/180744\/"},"modified":"2025-11-14T18:20:08","modified_gmt":"2025-11-14T18:20:08","slug":"texas-judge-in-tylenol-case-wont-block-kenvues-398-million-dividend-payment-lawyer-says","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/180744\/","title":{"rendered":"Texas judge in Tylenol case won&#8217;t block Kenvue&#8217;s $398 million dividend payment, lawyer says"},"content":{"rendered":"<ul data-testid=\"Summary\" class=\"summary-module__summary__QjADA\">\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Company has scheduled dividend payment for November 26<\/li>\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Paxton said Kenvue concealed Tylenol&#8217;s risks to kids when taken during pregnancy<\/li>\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Kenvue, Johnson &amp; Johnson, doctors say Tylenol is safe<\/li>\n<\/ul>\n<p>CARTHAGE, Texas, Nov 14 (Reuters) &#8211; A Texas state judge won&#8217;t block Kenvue <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/KVUE.N\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(KVUE.N), opens new tab<\/a> from paying its scheduled $398 million shareholder dividend on November 26, rejecting a request by state Attorney General Ken Paxton, a lawyer for the consumer health company told Reuters on Friday.<\/p>\n<p>Paxton, a Republican who is running for a U.S. Senate seat in 2026, sued Kenvue on October 28, accusing it of concealing the risks to children when pregnant women use Tylenol.<\/p>\n<p data-testid=\"promo-box\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__promo-box__hVl8h\"> Sign up  <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/legal\/litigation\/judge-weigh-if-texas-ag-can-block-kenvue-dividend-over-tylenol-2025-11-14\/undefined?location=article-paragraph&amp;redirectUrl=%2Flegal%2Flitigation%2Fjudge-weigh-if-texas-ag-can-block-kenvue-dividend-over-tylenol-2025-11-14%2F\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">here.<\/a><\/p>\n<p>The lawsuit was filed five weeks after Republican <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/trump-expected-link-autism-with-tylenol-experts-say-more-research-needed-2025-09-22\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">President Donald Trump<\/a> and U.S. Health and Human Services Secretary Robert F. Kennedy Jr. repeated the scientifically unproven claim that using the popular medication during pregnancy can cause autism.In September, the U.S. Food and Drug Administration told doctors to alert patients to what it said was growing evidence linking Tylenol use during pregnancy to autism. Medical societies <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/doctors-dismiss-trumps-warnings-reassure-pregnant-women-tylenol-is-ok-if-needed-2025-09-25\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">dispute a Tylenol link to autism<\/a>.<\/p>\n<p>Kenvue has repeatedly said Tylenol is safe.<\/p>\n<p>Judge LeAnn Rafferty in the Panola County courthouse in Carthage, Texas, near the Louisiana border, issued the ruling from the bench on Friday.<\/p>\n<p>Paxton&#8217;s office did not immediately respond to a request for comment.<\/p>\n<p>It is unusual for a local court, applying state law, to exercise power over issues fundamental to a multinational company&#8217;s business model, including its ability to communicate with the public and pay shareholders.<\/p>\n<p>Concerns about Tylenol have been an overhang for Kimberly-Clark&#8217;s <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/KMB.O\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(KMB.O), opens new tab<\/a> <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/kimberly-clark-acquire-kenvue-487-billion-deal-2025-11-03\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">planned $40 billion takeover<\/a> of Kenvue, which was announced six days after Paxton sued.That merger would let the maker of Kleenex and Huggies diapers expand into <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/kimberly-clarks-50-billion-leap-into-health-beauty-tests-investor-faith-2025-11-03\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">higher-margin categories<\/a> such as skin care and pain relief, by acquiring Kenvue brands including Band-Aid, Johnson&#8217;s Baby shampoo, Listerine and Neutrogena.<\/p>\n<p data-testid=\"SignOff\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__extra_small__8Buss body-module__full_width__kCIGb body-module__extra_small_body__Bfz20 sign-off-module__text__LQAMP\">Reporting by Jonathan Stempel and Sheila Dang; Additional reporting by Patrick Wingrove in New York and Tom Hals in Wilmington, Delaware; Editing by Noeleen Walder, Bill Berkrot and Paul Simao<\/p>\n<p data-testid=\"Body\" dir=\"ltr\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__element__5eCce article-body-module__trust-badge__5mS3f\">Our Standards: <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.thomsonreuters.com\/en\/about-us\/trust-principles.html\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__medium__2Rl30 text-module__small__sph8i link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">The Thomson Reuters Trust Principles., opens new tab<\/a><\/p>\n<p><a href=\"https:\/\/www.reutersagency.com\/en\/licensereuterscontent\/?utm_medium=rcom-article-media&amp;utm_campaign=rcom-rcp-lead\" target=\"_blank\" dir=\"ltr\" class=\"button-module__link__A3sD0 button-module__secondary__70gBu button-module__round__QDFgq button-module__w_auto__Sem-F\" data-testid=\"LicenceContentButton\" rel=\"nofollow noopener\">Purchase Licensing Rights<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Company has scheduled dividend payment for November 26 Paxton said Kenvue concealed Tylenol&#8217;s risks to kids when taken&hellip;\n","protected":false},"author":2,"featured_media":166317,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[82519,82794,82500,96599,82803,82530,87222,102139,87652,82802,83630,82531,84147,87219,82779,96598,18,45748,83117,102140,87209,135,87211,84906,19,17,82798,721,462,82565,82524,82575,82507,87201,102138,87647,82790,88152,82780,102141,2765,88228,88229,82508,1540,83810,84909,84910,82510,83002,82558,88225,96152,95751,98906,82534,88232,88137,82533,107,88148,83127],"class_list":{"0":"post-180744","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-amers","9":"tag-clj","10":"tag-cmpny","11":"tag-destef-business-future-of-health","12":"tag-destlit","13":"tag-destocabsm","14":"tag-destocap","15":"tag-destociv","16":"tag-destohlt","17":"tag-destolit","18":"tag-destoprod","19":"tag-destousbsm","20":"tag-destousdnm","21":"tag-destoushem","22":"tag-destoustpm","23":"tag-efbusiness-future-of-health","24":"tag-eire","25":"tag-gen","26":"tag-govact","27":"tag-gvgvf","28":"tag-hea","29":"tag-health","30":"tag-heca","31":"tag-hsehld","32":"tag-ie","33":"tag-ireland","34":"tag-judic","35":"tag-legal","36":"tag-medication","37":"tag-mtpix","38":"tag-namer","39":"tag-ncyc","40":"tag-news1","41":"tag-nrlpaocap","42":"tag-nrlpaociv","43":"tag-nrlpaohlt","44":"tag-nrlpaolit","45":"tag-nrlpaoprod","46":"tag-packageus-top-news","47":"tag-pbfact","48":"tag-phar","49":"tag-phar1","50":"tag-phmr","51":"tag-pol","52":"tag-potus","53":"tag-privt","54":"tag-psnpr","55":"tag-psnpr1","56":"tag-publ","57":"tag-pxp","58":"tag-reuters-legal","59":"tag-rhpilawsuits","60":"tag-rhpiregulatory","61":"tag-sanpro","62":"tag-sen","63":"tag-topcmb","64":"tag-topicpharma-healthcare-policy-regulation","65":"tag-topicworld-us-texas","66":"tag-topnws","67":"tag-us","68":"tag-usatx","69":"tag-wash"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/180744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=180744"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/180744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/166317"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=180744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=180744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=180744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}